Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integrative Medicine, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing 100142, China.
Chin J Cancer Res. 2011 Mar;23(1):74-8. doi: 10.1007/s11670-011-0074-7.
To evaluate the effect of Chinese herbs decoction Shu-Gan-Liang-Xue on endocrine therapy- associated hot flashes symptom in breast cancer patients.
Sixty-six patients with breast cancer receiving adjuvant endocrine therapy were categorized to two groups, the control group received endocrine therapy alone, the other group is administered with Chinese herbs decoction Shu-Gan-Liang-Xue besides the endocrine therapy: Shu-Gan-Liang-Xue decoction was administered above 6 months per year for more than 2 years. Frequency of hot flashes per day was recorded, and the effect of Shu-Gan-Liang-Xue decoction on hot flashes symptom being assessed with Kupperman Scoring Index.
Sixty cases were analyzed, 32 cases in endocrine therapy combining Chinese herbs decoction group, 28 cases in mere endocrine therapy group. For hot flashes symptom, in Chinese herbs decoction administration group, 7 cases (21.9%) reported symptom disappeared, 22 cases (68.7%) reported symptom alleviated, 3 cases (9.4%) reported symptom not changed; in endocrine therapy alone group, 5 cases (17.9%) reported symptom disappeared, 13 cases (46.4%) reported symptom alleviated, 10 cases (10/28, 35.7%) reported symptom not changed. The difference between two groups was statistically significant (P=0.013). For sleeping disorder, in Chinese herbs decoction administration group, 27 cases (84.4%) reported symptom improved, 5 cases (15.6%) reported no change; in endocrine therapy alone group, 16 cases (57.1%) symptom improved, 12 cases (42.9%) reported no change in sleeping disorder (P=0.019), the difference was also of significance statistically.
Long-term Chinese herbs decoction administration remarkably improved hot flashes symptom and sleeping disorder associated with endocrine therapy, meanwhile without definite toxicity and influence on the risk of recurrence of tumor.
评价中药方剂疏肝凉血清对乳腺癌患者内分泌治疗相关潮热症状的影响。
将 66 例接受辅助内分泌治疗的乳腺癌患者分为两组,对照组仅接受内分泌治疗,观察组在接受内分泌治疗的基础上给予中药方剂疏肝凉血清治疗:每年服用中药方剂超过 6 个月,连续服用超过 2 年。记录每天潮热的发生频率,并采用 Kupperman 评分指数评估疏肝凉血清汤对潮热症状的影响。
对 60 例患者进行分析,内分泌治疗联合中药组 32 例,单纯内分泌治疗组 28 例。在潮热症状方面,中药组 7 例(21.9%)报告症状消失,22 例(68.7%)报告症状缓解,3 例(9.4%)报告症状无变化;单纯内分泌治疗组 5 例(17.9%)报告症状消失,13 例(46.4%)报告症状缓解,10 例(10/28,35.7%)报告症状无变化。两组差异有统计学意义(P=0.013)。在睡眠障碍方面,中药组 27 例(84.4%)报告症状改善,5 例(15.6%)报告无变化;单纯内分泌治疗组 16 例(57.1%)症状改善,12 例(42.9%)报告睡眠障碍无变化(P=0.019),差异也有统计学意义。
长期服用中药方剂可显著改善内分泌治疗相关的潮热症状和睡眠障碍,同时无明确的毒性作用,也不会影响肿瘤复发的风险。